22-Aug-2003 - Oxford Instruments plc

Oxford Instruments wins major order enabling a new generation of Mass Spectrometry based bio-tools

Oxford Instruments Superconductivity has been selected as a key supplier of superconducting magnet technology to Thermo Electron Corporation (NYSE:TMO) that will enable a new generation of bio-tools for medical and scientific research. The award winning world's first commercially available, high performance Hybrid Ion Trap - Fourier Transform Mass Spectrometer (LTQ FTTM) will use Oxford Instruments' superconducting magnet technology to help deliver its high performance specification. The Fourier Transform Mass Spectrometer (FTMS) platform developed by Thermo Electron represents a paradigm shift in mass spectrometry, as it transforms a highly complex technology into an instrument ideal for use in routine pharmaceutical and biochemical research. Oxford Instruments' superconducting magnet is a critical enabling element at the heart of the instrument, which will play a major role in future drug discovery and life science applications. By uniquely combining high resolution, accurate mass determinations with MSn, Thermo Electron's highly advanced Finnigan(TM) LTQ-FTTM facilitates the precise elucidation of protein structure and function. The information gained from this new bio-tool will increase knowledge on biological function and ultimately assist in the advancement of novel drug discovery, diagnostic and therapeutic solutions. Oxford Instruments underwent a rigorous supplier selection process where it demonstrated the consistent quality of its magnets, critical for the delivery of such a high performance technique as Finnigan LTQ-FTTM. A further factor for consideration was the expected exponential growth of the Finnigan LTQ-FTTM market over the next five years. It was, therefore, essential that a primary supplier could meet all these exacting demands in terms of both quality and supply. The supplier agreement is estimated to be worth EUR 3m over the next 18 months with EUR 1m already committed. FTMS platforms are well positioned to help advance the needs of many life science and pharmaceutical analytical applications and it is expected that advances in FTMS will enable significant growth opportunities.

Facts, background information, dossiers
  • Biotools
  • protein structure
More about Oxford Instruments
  • News

    WITec joins Oxford Instruments

    The management team of WITec GmbH announced that WITec was acquired by Oxford Instruments plc, a UK based company that has a great reputation in the scientific community, and in the future will be part of their Materials Analysis Group. WITec’s founders Dr. Joachim Koenen and Dr. Olaf Hollr ... more

    Oxford Instruments achieves the first 22 Tesla at 4.2 Kelvin fully superconducting magnet using LTS and HTS materials

    Oxford Instruments has achieved 22.07 Tesla in a fully superconducting magnet operating at 4.2 Kelvin, the result of continuing efforts into studying the application of HTS high temperature superconducting and LTS low temperature superconducting technology in the manufacture of high magneti ... more

    Oxford Instruments acquires Link Analytical

    Oxford Instruments plc announced the acquisition of the business and assets of Link Analytical AB from Anna Otterstrom, the current owner/manager. Link's primary activity is the distribution and after-sales support of Oxford Instruments NanoAnalysis equipment in Scandinavia. The acquisitio ... more

  • Companies

    Oxford Instruments GmbH

    Oxford Instruments specialises in the design, manufacture and support of high-technology tools and systems for industry, research, education, space, energy, defence and healthcare. We combine core technologies in areas such as low temperature and high magnetic field environments; X-ray, el ... more